Changing Course: Treatment Options for Lymphoma Relapse Following CAR-T Therapy
Join us for this virtual webinar with Dr. Megan Melody, lymphoma and cellular therapy specialist, to learn about the treatment options that are available after disease relapse following CAR-T therapy.
Hannah introduces the agenda and our featured speaker Megan Melody, MD, MS
Megan Melody, MD, MS talks about treatment options for relapse after CAR-T therapy
Come with your questions and we will answer them!
Megan Melody, MD, MS
Dr. Megan Melody is a hematologist/oncologist at Tampa General Hospital Cancer Institute who specializes in lymphoma and cellular therapies. Dr. Melody completed her residency at the Mayo Clinic in Jacksonville, Fl and fellowship in hematology and oncology at Northwestern University in Chicago, IL where she was appointed Chief Fellow during her final year of fellowship. Dr. Melody’s research focuses on lymphoma (primarily Hodgkin and large B-cell lymphoma) and cellular therapies including hematopoietic stem cell transplantation, chimeric antigen receptor (CAR) T-cell therapy, and bispecific antibodies. She has been credited with several peer-reviewed publications, abstracts, and book chapters in her areas of expertise and has presented her research at the regional, national, and international level. She is passionate about improving patient outcomes and reducing treatment related toxicities in the field of hematologic malignancies.
Hannah Loosle
Hannah joined HealthTree Foundation as the Lymphoma Education Manager in 2024. She is a Certified Health Education Specialist and is passionate about helping patients feel empowered through education and connection. Before joining HealthTree, Hannah worked in healthcare policy helping patients advocate for better care, research, and funding. Hannah enjoys baking and going to concerts in her free time.